ArticleTranslational lung cancer research2025

Monitoring pembrolizumab response in patients with metastatic non-small cell lung cancer using circulating tumour DNA and circulating tumour cells.

Andrea C Kakouri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.